List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 38 studies with search of: pulmonary hypertension Mayo
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management
Condition: Pulmonary Hypertension
Intervention:
2 Recruiting Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Interventions: Drug: bosentan;   Drug: placebo
3 Completed Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: Ambrisentan
4 Completed Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: UT-15
5 Completed Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Pulmonary Hypertension
Intervention: Drug: bosentan
6 Completed Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
Condition: Chronic Thromboembolic Pulmonary Hypertension
Intervention: Drug: bosentan
7 Recruiting Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)
Conditions: Systemic Sclerosis;   Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Intervention:
8 Terminated FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Intervention: Drug: Oral Treprostinil (UT-15C) Sustained Release Tablets
9 Active, not recruiting Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis;   Hypertension, Pulmonary
Interventions: Drug: Sildenafil Citrate;   Other: Placebo
10 Completed Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: BSF 208075
11 Completed Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   PAH;   Pulmonary Hypertension
Intervention: Drug: Iloprost or placebo
12 Recruiting A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension (FREEDOM-C2)
Condition: Pulmonary Hypertension
Intervention: Drug: UT-15C
13 Recruiting FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Intervention: Drug: Oral treprostinil (UT-15C) Sustained Release Tablets
14 Active, not recruiting ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Intervention: Drug: Ambrisentan
15 Completed FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension
Intervention: Drug: Oral treprostinil (UT-15C) Sustained Release Tablets
16 Active, not recruiting Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: sitaxsentan sodium
17 Completed Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Iloprost Inhalation Solution (Ventavis)
18 Recruiting Combination Therapy in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: bosentan;   Drug: bosentan and sildenafil combination
19 Enrolling by invitation Long-term Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: ACT-064992
20 Recruiting Scleroderma: Cyclophosphamide or Transplantation (SCOT)
Conditions: Scleroderma, Systemic;   Sclerosis;   Autoimmune Disease
Interventions: Procedure: Autologous stem cell transplantation and High-dose immunosuppressive therapy (HDIT);   Drug: Cyclosphosphamide;   Drug: Equine antithymocyte globulin;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Radiation: Total body irradiation (TBI)

Previous Page Studies Shown (1-20) Next Page (21-38)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services